Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETF

iShares Global Healthcare ETF (NYSEMKT:IXJ) provides wide planetary vulnerability and market-cap weighting, whereas Invesco S&P 500 Equal Weight Health Care ETF (NYSEMKT:RSPH) focuses connected U.S. ample caps with a circumstantial equal-weighting mandate that reduces attraction risk.

Both funds connection targeted vulnerability to the healthcare assemblage but disagree importantly successful their geographic scope and construction. While RSPH levels the playing tract among 60 home giants, IXJ captures 110 planetary leaders, including large European pharmaceutical companies. With $4.1 cardinal successful assets nether absorption (AUM), the iShares money offers substantially higher liquidity than its $734.1 cardinal Invesco counterpart.

Snapshot (cost & size)

Beta measures terms volatility comparative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr instrumentality represents full instrumentality implicit the trailing 12 months. Dividend output is the trailing-12-month organisation yield.

Both ETFs transportation an identical 0.40% disbursal ratio, which is comparatively businesslike for specialized assemblage funds. However, the iShares money offers a notably higher dividend output of 1.50%, providing much income for yield-seekers than the 0.70% payout provided by the Invesco fund.

Performance & hazard examination

The iShares Global Healthcare ETF provides vulnerability to 110 planetary healthcare stocks, capturing assemblage leaders crossed planetary markets. Its largest positions see Eli Lilly astatine 10.6%, Johnson & Johnson astatine 7.1%, and AbbVie astatine 5%. This money was launched successful 2001. It has paid $1.44 per stock implicit the trailing 12 months, which connected its caller ~$99.21 stock terms works retired to a 1.50% yield.

In contrast, the Invesco S&P 500 Equal Weight Health Care ETF tracks the S&P 500 Equal Weight Health Care Index and holds 60 stocks. The money employs an equal-weighting strategy that is adjusted connected a quarterly basis. Its largest positions see Moderna astatine 2.35%, Bio-Techne astatine 2.2%, and Charles River Laboratories International astatine 2%. This money was launched successful 2006. It has paid $0.23 per stock implicit the trailing 12 months, which connected its caller ~$33.98 stock terms works retired to a 0.70% yield.

For much guidance connected ETF investing, cheque retired the afloat usher astatine this link.